TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $411,136 | -67.7% | 49,179 | -4.0% | 0.00% | -60.0% |
| Q2 2023 | $1,272,081 | +38.1% | 51,211 | -16.4% | 0.01% | +25.0% |
| Q1 2023 | $921,305 | -51.1% | 61,257 | -61.5% | 0.00% | -55.6% |
| Q4 2022 | $1,884,637 | +95.1% | 159,310 | -2.4% | 0.01% | +80.0% |
| Q3 2022 | $966,000 | +79.2% | 163,215 | +28.8% | 0.01% | +66.7% |
| Q2 2022 | $539,000 | +450.0% | 126,706 | +1135.0% | 0.00% | – |
| Q1 2022 | $98,000 | -66.3% | 10,260 | +36.7% | 0.00% | -100.0% |
| Q2 2021 | $291,000 | -49.9% | 7,505 | -37.7% | 0.00% | -66.7% |
| Q1 2021 | $581,000 | +157.1% | 12,050 | +3.9% | 0.00% | +200.0% |
| Q2 2020 | $226,000 | – | 11,598 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |